Santersus AG
PrivateLast Round
Series A
Dec 1, 2025
Total Funding Raised
$810,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Santersus AG operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Series A round in December 2025.
Santersus AG is a biotechnology company that develops NucleoCapture, a patent-protected extracorporeal blood purification technology designed to selectively remove cell-free DNA and neutrophil extracellular traps from patient blood to treat conditions such as sepsis, systemic lupus erythematosus, and organ transplant complications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Santersus AG Comparables
Compare Santersus AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hemotune AG | 82% | |
| ExThera Medical | 78% | |
| Cytosorbents Corporation | 74% |
For institutional investors. Book with your work email.
Santersus AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 1, 2025 | ||||
| Seed | Sep 1, 2021 | ||||
| Seed | Jul 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Santersus AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Terumo Ventures | Series A |
| Norcliffe Capital Limited | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Grew 38% QoQ, from 8 to 11 employees.
- Dec 1, 2025
Led by Norcliffe Capital Limited with participation from Terumo Ventures.
For institutional investors. Book with your work email.
Santersus AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Santersus AG's valuation, stock price, and market status.
Is Santersus AG a public or private company?
Santersus AG is a private company.
What is the current stock price of Santersus AG?
Santersus AG is a private company, so its shares have no public market price. Caplight tracks Santersus AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Santersus AG worth (valuation)?
Valuation information for Santersus AG is not publicly available.
Can I buy Santersus AG stock?
Santersus AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Santersus AG's last funding round?
Santersus AG's most recent funding round was Series A on December 1, 2025.
Who are the main investors in Santersus AG?
Key investors in Santersus AG include Norcliffe Capital Limited.
Will Santersus AG IPO soon?
No public IPO plans have been announced for Santersus AG.
How can I track Santersus AG secondary market activity?
Caplight tracks bids, offers, and trades in Santersus AG's shares on secondary markets.